Logos Global Management LP → ALX ONCOLOGY HOLDINGS INC ALXO

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 16/100 · Filer 90d Win Rate: 100% · Hist. 90d Edge: +42.7%

Passive Schedule 13G filer baseline
Moderate short days-to-cover (3.6 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 3.63

5,976,398 shares short · +5.3% vs prior

Other 13D/G Filings on ALX ONCOLOGY HOLDINGS INC

Filed	Form	Filer	Stake	Shares
2026-10-16	SCHEDULE 13D/A	venBio Global Strategic Fund, L.P.	9.99%	4,307,034	view →
2026-07-27	SCHEDULE 13G	BlackRock, Inc.	—	—	view →
2026-05-27	SCHEDULE 13D/A	LSV Associates, LLC	2.20%	1,549,132	view →

Other Filings by Logos Global Management LP

Filed	Form	Issuer	Stake	Shares
2026-09-10	SCHEDULE 13G	Longeveron Inc.	—	—	view →
2026-08-17	SCHEDULE 13G	ACHIEVE LIFE SCIENCES, INC.	—	—	view →
2025-08-22	SCHEDULE	ARVINAS, INC. ARVN	8.60%	6,300,000	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →